These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9103332)

  • 1. From the Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    JAMA; 1997 Apr; 277(15):1193-4. PubMed ID: 9103332
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].
    Partosch F; Stahlmann R
    Med Monatsschr Pharm; 2011 Oct; 34(10):358-62. PubMed ID: 22010419
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ACE inhibition on the fetal kidney: decreased renal blood flow.
    Martin RA; Jones KL; Mendoza A; Barr M; Benirschke K
    Teratology; 1992 Oct; 46(4):317-21. PubMed ID: 1412062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors in pregnancy.
    Mastrobattista JM
    Semin Perinatol; 1997 Apr; 21(2):124-34. PubMed ID: 9201818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitor fetopathy.
    Hegde AU; Parekji S; Ali US; Mehta KP
    Indian Pediatr; 1999 Jan; 36(1):79-82. PubMed ID: 10709127
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.
    Polifka JE
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):576-98. PubMed ID: 22807387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting-enzyme inhibitors in early pregnancy.
    Lip GY; Churchill D; Beevers M; Auckett A; Beevers DG
    Lancet; 1997 Nov; 350(9089):1446-7. PubMed ID: 9371172
    [No Abstract]   [Full Text] [Related]  

  • 10. [Captopril use in pregnancy and its effects on the fetus and the newborn: case report].
    Sadeck LS; Fernandes M; Silva SM; Trindade AA; Chia CY; Ramos JL; Leone CR
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(6):328-32. PubMed ID: 9629744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are ACE inhibitors safe in pregnancy?
    Lancet; 1989 Aug; 2(8661):482-3. PubMed ID: 2570189
    [No Abstract]   [Full Text] [Related]  

  • 12. Newer antihypertensive agents in pregnancy.
    Hennessy A; Horvath JS
    Med J Aust; 1992 Mar; 156(5):304-5. PubMed ID: 1588859
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors.
    Brent RL; Beckman DA
    Teratology; 1991 Jun; 43(6):543-6. PubMed ID: 1882342
    [No Abstract]   [Full Text] [Related]  

  • 14. Pregnancy outcome with ACE-inhibitor use in early pregnancy.
    Steffensen FH; Nielsen GL; Sørensen HT; Olesen C; Olsen J
    Lancet; 1998 Feb; 351(9102):596. PubMed ID: 9492804
    [No Abstract]   [Full Text] [Related]  

  • 15. Taking ACE inhibitors during early pregnancy: is it safe?
    Ray JG; Vermeulen MJ; Koren G
    Can Fam Physician; 2007 Sep; 53(9):1439-40. PubMed ID: 17872870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure.
    Chisholm CA; Chescheir NC; Kennedy M
    Am J Perinatol; 1997 Oct; 14(9):511-3. PubMed ID: 9394157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
    Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
    Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant primary hypertension in pregnancy treated with lisinopril.
    Tomlinson AJ; Campbell J; Walker JJ; Morgan C
    Ann Pharmacother; 2000 Feb; 34(2):180-2. PubMed ID: 10676826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions to drugs: angiotensin-converting enzyme inhibitors and pregnancy.
    Birbari AE
    J Med Liban; 1993; 41(2):99. PubMed ID: 8057352
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.
    Pucci M; Sarween N; Knox E; Lipkin G; Martin U
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):221-31. PubMed ID: 25612630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.